Literature DB >> 3488198

Plasmid-mediated beta-lactamase in Branhamella catarrhalis.

C Kamme, I Eliasson, B K Knutson, M Vang.   

Abstract

The plasmid-mediated beta-lactamase in Branhamella catarrhalis (BRO-1), also occurring in Moraxella nonliquefaciens, differs from other known plasmid-mediated beta-lactamases in Gram-negative bacteria regarding substrate profile and isoelectric point. B. catarrhalis strains previously reported to produce beta-lactamases deviating from BRO-1 were tested, and the beta-lactamases did not differ significantly from BRO-1 in substrate profile, isoelectric point or relative substrate affinity index (RSAI). Further investigations of strains of various geographic origin should be undertaken. RSAI seems to be a useful tool for screening of beta-lactamases in B. catarrhalis since values for a large number of strains can easily be determined. The previously reported conjugational transfer of BRO-1 production within species B. catarrhalis and from M. nonliquefaciens to B. catarrhalis was confirmed. Four bands of extrachromosomal DNA were regularly detected by agarose gel electrophoresis in beta-lactamase-producing as well as in beta-lactamase-negative strains of B. catarrhalis and M. non-liquefaciens, provided that the excessive nuclease activity in the preparations was inhibited.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488198     DOI: 10.2165/00003495-198600313-00013

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  23 in total

1.  Novel beta-lactamase from Branhamella catarrhalis.

Authors:  A B Hoi-Dang; C Brive-Le Bouguenec; M Barthelemy; R Labia
Journal:  Ann Microbiol (Paris)       Date:  1978-10

2.  Beta-lactamase production in commensal Neisseriaceae.

Authors:  P Piot; M Roberts; G Ninane
Journal:  Lancet       Date:  1979-03-17       Impact factor: 79.321

3.  Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis.

Authors:  A Percival; J E Corkill; J Rowlands; R B Sykes
Journal:  Lancet       Date:  1977-12-03       Impact factor: 79.321

4.  Transfer of ampicillin resistance between strains of Haemophilus influenzae type B.

Authors:  G M Thorne; W E Farrar
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

5.  Carbenicillin-hydrolyzing penicillinases of Proteus mirabilis and the PSE-type penicillinases of Pseudomonas aeruginosa.

Authors:  I Takahashi; K Tsukamoto; M Harada; T Sawai
Journal:  Microbiol Immunol       Date:  1983       Impact factor: 1.955

6.  Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase.

Authors:  L G Rubin; A A Medeiros; R H Yolken; E R Moxon
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

7.  Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid.

Authors:  J A Meyers; D Sanchez; L P Elwell; S Falkow
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

8.  Partial amino acid sequence of penicillinase coded by Escherichia coli plasmid R6K.

Authors:  R P Ambler; G K Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

9.  A plasmid-mediated cephalosporinase from Achromobacter species.

Authors:  R Levesque; P H Roy; R Letarte; J C Pechère
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

10.  Penicillinase-producing Neisseria gonorrhoeae in the Netherlands: epidemiology and genetic and molecular characterization of their plasmids.

Authors:  J D van Embden; B van Klingeren; M Dessens-Kroon; L J van Wijngaarden
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

View more
  10 in total

1.  Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia.

Authors:  C DiGiovanni; T V Riley; G F Hoyne; R Yeo; P Cooksey
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

Review 2.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

3.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors:  R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 4.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

5.  Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.

Authors:  H J Bootsma; H van Dijk; J Verhoef; A Fleer; F R Mooi
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

6.  Tetracycline resistance in Moraxella (Branhamella) catarrhalis: demonstration of two clonal outbreaks by using pulsed-field gel electrophoresis.

Authors:  M C Roberts; Y J Pang; R C Spencer; T G Winstanley; B A Brown; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

7.  Characterization of cell-bound papain-soluble beta-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens.

Authors:  I Eliasson; C Kamme; M Vang; S G Waley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

8.  Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.

Authors:  A Saito; K Yamaguchi; Y Shigeno; S Kohno; H Shigeno; N Kusano; Y Dotsu; K Hara
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States.

Authors:  D R Nash; R J Wallace; V A Steingrube; P A Shurin
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  Moraxella catarrhalis NucM is an entry nuclease involved in extracellular DNA and RNA degradation, cell competence and biofilm scaffolding.

Authors:  Aimee Tan; Wing-Sze Li; Anthony D Verderosa; Luke V Blakeway; Tsitsi D Mubaiwa; Makrina Totsika; Kate L Seib
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.